Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Krystal Biotech Inc increased its cash reserves by 121.33%, or 196.43m. Cash Flow from Financing totalled 202.75m or 399.91% of revenues. In addition the company used 88.80m for operations while cash from investing totalled 82.64m.
Cash flow per share | 2.02 |
---|---|
Price/Cash flow per share | 96.63 |
Book value per share | 30.80 |
---|---|
Tangible book value per share | 30.80 |
More ▼
Balance sheet in USDView more
Current ratio | 7.97 |
---|---|
Quick ratio | 7.76 |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼